Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods

被引：47

作者：

Thomas M. ^{[1
]}

Vajaranant T.S. ^{[1
]}

Aref A.A. ^{[1
]}

机构：

[1] University of Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois Hospital and Health System, Chicago, IL

来源：

Ophthalmology and Therapy | 2015年 / 4卷 / 2期

关键词：

Glaucoma filtration surgery; Hypotony; Hypotony maculopathy; Retina;

D O I：

10.1007/s40123-015-0037-z

中图分类号：

学科分类号：

摘要：

Introduction: Hypotony maculopathy is ocular hypotony complicated by papilledema and/or folding of the retina and choroid in the posterior pole. Our objective was to examine the current literature regarding hypotony maculopathy and treatment methods. Methods: A systematic review of the English-language literature was conducted by performing a broad search of PubMed from 1972 through 2015 using the keywords hypotony maculopathy and hypotony. Additional articles were identified from bibliographies of relevant articles. Results: Hypotony maculopathy was infrequent before the introduction of antimetabolite agents in glaucoma-filtering surgery, and the incidence of this entity is now up to 20%. Risk factors for developing hypotony maculopathy include male gender, young age, myopia, and primary filtering surgery. Correctly identifying the etiology of hypotony is essential for successful treatment. Treatment of hypotony maculopathy includes procedures to elevate the intraocular pressure, thus reversing the collapse of the scleral wall and chorioretinal wrinkling. Conclusion: This review discusses the definition, clinical presentation, pathophysiology, incidence and risk factors, prevention and treatment of hypotony maculopathy. © 2015, The Author(s).

引用

页码：79 / 88

页数：9

共 47 条

[11]

Costa V.P., Arcieri E.S., Hypotony maculopathy, Acta Ophthalmol Scand, 85, pp. 586-597, (2007)

[12]

Costa V.P., Wilson R.P., Moster M.R., Schmidt C.M., Gandham S., Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery, Ophthalmic Surg, 24, pp. 389-394, (1993)

[13]

Rasheed el-S null, Initial trabeculectomy with intraoperative mitomycin-C application in primary glaucomas, Ophthalmic Surg Lasers, 30, pp. 360-366, (1999)

[14]

Rulli E., Biagioli E., Riva I., Gambirasio G., De Simone I., Floriani I., Et al., Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis, JAMA Ophthalmol, 131, pp. 1573-1582, (2013)

[15]

Nuyts R.M., Greve E.L., Geijssen H.C., Langerhorst C.T., Treatment of hypotonous maculopathy after trabeculectomy with mitomycin C, Am J Ophthalmol, 118, pp. 322-331, (1994)

[16]

Yun S.T., Chua B., Clement C.I., Outcomes of chronic hypotony following trabeculectomy, Clin Exp Ophthalmol., 43, pp. 485-487, (2014)

[17]

Costa V.P., Smith M., Spaeth G.L., Gandham S., Markovitz B., Loss of visual acuity after trabeculectomy, Ophthalmology, 100, pp. 599-612, (1993)

[18]

Edmunds B., Thompson J.R., Salmon J.F., Wormald R.P., The national survey of trabeculectomy. III. Early and late complications, Eye (Lond), 16, pp. 297-303, (2002)

[19]

Hatton M.P., Perez V.L., Dohlman C.H., Corneal oedema in ocular hypotony, Exp Eye Res, 78, pp. 549-552, (2004)

[20]

Ding C., Zeng J., Clinical study on hypotony following blunt ocular trauma, Int J Ophthalmol, 5, pp. 771-773, (2012)

← 1 2 3 4 5 →